Expression and inducibility by phenobarbital of CYP2C33, CYP2C42, CYP2C49, CYP2B22, and CYP3As in porcine liver, kidney, small intestine, and nasal tissues

References

• Amato G, Longo V, Mazzaccaro A, Gervasi PG. (1996). Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver. Chem Res Toxicol 9:882–890.
   PubMedGoogle Scholar
• Anzenbacher P, Soucek P, Anzenbacherová E, Gut I, Hrubý K, Svoboda Z, Kvetina J. (1998). Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples. Drug Metab Dispos 26:56–59.
   PubMed Web of Science ®Google Scholar
• Bièche I, Narjoz C, Asselah T, Vacher S, Marcellin P, Lidereau R, Beaune P, de Waziers I. (2007). Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics 17:731–742.
   PubMed Web of Science ®Google Scholar
• Chen Y, Ferguson SS, Negishi M, Goldstein JA. (2004). Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor. J Pharmacol Exp Ther 308:495–501.
   PubMed Web of Science ®Google Scholar
• Chirulli V, Marvasi L, Zaghini A, Fiorio R, Longo V, Gervasi PG. (2007). Inducibility of AhR-regulated CYP genes by beta-naphthoflavone in the liver, lung, kidney and heart of the pig. Toxicology 240:25–37.
   PubMed Web of Science ®Google Scholar
• Choi MH, Skipper PL, Wishnok JS, Tannenbaum SR. (2005). Characterization of testosterone 11 beta-hydroxylation catalyzed by human liver microsomal cytochromes P450. Drug Metab Dispos 33:714–718.
   PubMed Web of Science ®Google Scholar
• Desille M, Corcos L, L’Helgoualc’h A, Frémond B, Campion JP, Guillouzo A, Clément B. (1999). Detoxifying activity in pig livers and hepatocytes intended for xenotherapy. Transplantation 68:1437–1443.
   PubMed Web of Science ®Google Scholar
• Donato MT, Castell JV, Gómez-Lechón MJ. (1999). Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. J Hepatol 31:542–549.
   PubMed Web of Science ®Google Scholar
• Ekins S, VandenBranden M, Ring BJ, Wrighton SA. (1997). Examination of purported probes of human CYP2B6. Pharmacogenetics 7:165–179.
   PubMedGoogle Scholar
• Faucette SR, Sueyoshi T, Smith CM, Negishi M, Lecluyse EL, Wang H. (2006). Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor. J Pharmacol Exp Ther 317:1200–1209.
   PubMed Web of Science ®Google Scholar
• Ferguson SS, Chen Y, LeCluyse EL, Negishi M, Goldstein JA. (2005). Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha. Mol Pharmacol 68:747–757.
   PubMed Web of Science ®Google Scholar
• Flanagan JU, McLaughlin LA, Paine MJ, Sutcliffe MJ, Roberts GC, Wolf CR. (2003). Role of conserved Asp293 of cytochrome P450 2C9 in substrate recognition and catalytic activity. Biochem J 370:921–926.
   Google Scholar
• Gerbal-Chaloin S, Pascussi JM, Pichard-Garcia L, Daujat M, Waechter  F, Fabre JM, Carrère N, Maurel P. (2001). Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab Dispos 29:242–251.
   PubMed Web of Science ®Google Scholar
• Goldstein JA, de Morais SM. (1994). Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4:285–299.
   PubMedGoogle Scholar
• Guengerich FP. (1997). Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chem Biol Interact 106:161–182.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. (2005). Human cytochrome P450 enzymes. In: Ortiz de Montellano PR, ed. Cytochrome P450, structure, mechanism and biochemistry, 3rd ed. New York: Kluwer Academic/Plenum Publishers, p. 377–463.
   Google Scholar
• Imaoka S, Yamada T, Hiroi T, Hayashi K, Sakaki T, Yabusaki Y, Funae Y. (1996). Multiple forms of human P450 expressed in Saccaharomyces cerevisiae. Biochem Pharmacol 51:1041–1030.
   PubMed Web of Science ®Google Scholar
• Inoue K, Negishi M. (2008). Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P450 2B6 gene. J Biol Chem 283:10425–10432.
   Google Scholar
• Ko JW, Desta Z, Flockhart DA. (1998). Human N-demethylation of (S)-mephenytoin by cytochrome P450s 2C9 and 2B6. Drug Metab Dispos 26:775–778.
   PubMed Web of Science ®Google Scholar
• Kojima M, Morozumi T. (2004). Cloning of six full-length cDNAs encoding pig cytochrome P450 enzymes and gene expression of these enzymes in the liver and kidney. J Health Sci 50:518–529.
   Web of Science ®Google Scholar
• Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685.
   PubMed Web of Science ®Google Scholar
• Li XQ, Björkman A, Andersson TB, Ridderström M, Masimirembwa  CM. (2002). Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate. J Pharmacol Exp Ther 300:399–407.
   PubMed Web of Science ®Google Scholar
• Longo V, Mazzaccaro A, Naldi F, Gervasi PG. (1991). Drug-metabolizing enzymes in liver, olfactory, and respiratory epithelium of cattle. J Biochem Toxicol 6:123–128.
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275.
   PubMed Web of Science ®Google Scholar
• Madan A, Graham RA, Carroll KM, Mudra DR, Burton LA, Krueger  LA, Downey AD, Czerwinski M, Forster J, Ribadeneira MD, Gan  LS, LeCluyse EL, Zech K, Robertson P, Jr Koch, P, Antonian L, Wagner  G, Yu L, Parkinson A. (2003). Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos 31:421–431.
   PubMed Web of Science ®Google Scholar
• Mancy A, Antignac M, Minoletti C, Dijols S, Mouries V, Duong NT, Battioni P, Dansette PM, Mansuy D. (1999). Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs. Biochemistry 38:14264–14270.
   PubMed Web of Science ®Google Scholar
• Mancy A, Dijols S, Poli S, Guengerich P, Mansuy D. (1996). Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9. Biochemistry 35:16205–16212.
   PubMed Web of Science ®Google Scholar
• Marini S, Grasso E, Longo V, Puccini P, Riccardi B, Gervasi PG. (2003). 4-Biphenylaldehyde and 9-anthraldehyde: two fluorescent substrates for determining P450 enzyme activities in rat and human. Xenobiotica 33:1–11.
   PubMed Web of Science ®Google Scholar
• Meier UT, Kronbach T, Meyer UA. (1985). Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography. Anal Biochem 151:286–291.
   PubMedGoogle Scholar
• Messina A, Nannelli A, Fiorio R, Longo V, Gervasi PG. (2009). Expression and inducibility of CYP1A1, 1A2, 1B1 by beta-naphthoflavone and CYP2B22, 3A22, 3A29, 3A46 by rifampicin in the respiratory and olfactory mucosa of pig. Toxicology 260:47–52.
   PubMed Web of Science ®Google Scholar
• Miners JO, Birkett DJ. (1998). Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol 45:525–538.
   PubMed Web of Science ®Google Scholar
• Miners JO, Smith KJ, Robson RA, McManus ME, Veronese ME, Birkett DJ. (1998). Tolbutamide hydroxylation by human liver microsomes. Kinetic characterization and relation ship to other cytochrome P450 dependent xenobiotic oxidations. Biochem Pharmacol 37:1137–1344.
   Google Scholar
• Moore LB, Maglich JM, McKee DD, Wisely B, Willson TM, Kliewer  SA, Lambert MH, Moore JT. (2002). Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol Endocrinol 16:977–986.
   PubMed Web of Science ®Google Scholar
• Monshouwer M, van’t Klooster GAE, Nijmeijer SM, Witkamp RF, van Miert ASJPAM. (1998). Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes. Toxicol In Vitro 12:715–723.
   Google Scholar
• Myers MJ, Farrell DE, Howard KD, Kawalek JC. (2001). Identification of multiple constitutive and inducible hepatic cytochrome P450 enzymes in market weight swine. Drug Metab Dispos 29:908–915.
   PubMed Web of Science ®Google Scholar
• Nannelli A, Chirulli V, Longo V, Gervasi PG. (2008). Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig. Toxicology 252:105–112.
   PubMed Web of Science ®Google Scholar
• Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert  DW. (2004). Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1–18.
   PubMedGoogle Scholar
• Niimi S, Kim EY, Iwata H, Watanabe MX, Yasunaga G, Fujise Y, Tanabe S. (2007). Identification and hepatic expression profiles of cytochrome P450 1–4 isozymes in common minke whales (Balaenoptera acutorostrata). Comp Biochem Physiol B, Biochem Mol Biol 147:667–681.
   Google Scholar
• Nishimura M, Naito S, Yokoi T. (2004). Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies. Drug Metab Pharmacokinet 19:135–149.
   PubMedGoogle Scholar
• Nissen PH, Winterø AK, Fredholm M. (1998). Mapping of porcine genes belonging to two different cytochrome P450 subfamilies. Anim Genet 29:7–11.
   PubMed Web of Science ®Google Scholar
• Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM. (2006). The utility of in vitro cytochrome P450 inhibition data in the prediction of drug–drug interactions. J Pharmacol Exp Ther 316:336–348.
   PubMed Web of Science ®Google Scholar
• Skaanild MT. (2006). Porcine cytochrome P450 and metabolism. Curr Pharm Des 12:1421–1427.
   PubMed Web of Science ®Google Scholar
• Skaanild MT, Friis C. (2008). Analyses of CYP2C in porcine microsomes. Basic Clin Pharmacol Toxicol 103:487–492.
   Google Scholar
• Soucek P, Zuber R, Anzenbacherová E, Anzenbacher P, Guengerich FP. (2001). Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs. BMC Pharmacol 1:11.
   PubMedGoogle Scholar
• Stresser DM, Blanchard AP, Turner SD, Erve JC, Dandeneau AA, Miller VP, Crespi CL. (2000). Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metab Dispos 28:1440–1448.
   PubMed Web of Science ®Google Scholar
• Stresser DM, Turner SD, Blanchard AP, Miller VP, Crespi CL. (2002). Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab Dispos 30:845–852.
   PubMed Web of Science ®Google Scholar
• Totah RA, Rettie AE. (2005). Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance. Clin Pharmacol Ther 77:341–352.
   PubMed Web of Science ®Google Scholar
• Towbin H, Staehelin T, Gordon J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354.
   PubMed Web of Science ®Google Scholar
• Vaclavikova R, Soucek P, Svobodova L, Anzenbacher P, Simek P, Guengerich FP, Gut I. (2004). Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs. Drug Metab Dispos 32:666–674.
   PubMed Web of Science ®Google Scholar
• Zaphiropoulos PG, Skantz A, Eliasson M, Ahlberg MB. (1995). Cytochrome P450 genes expressed in porcine ovaries: identification of novel forms, evidence for gene conversion, and evolutionary relationships. Biochem Biophys Res Commun 212:433–441.
   PubMed Web of Science ®Google Scholar
• Zhou HH, Anthony LB, Wood AJ, Wilkinson GR. (1990). Induction of polymorphic 4-hydroxylation of S-mephenytoin by rifampicin. Br J Clin Pharmacol 30:471–475.
   PubMed Web of Science ®Google Scholar
• Zilly W, Breimer DD, Richter E. (1975). Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance. Eur J Clin Pharmacol 9:219–227.
   PubMed Web of Science ®Google Scholar